Similar articles

• Enhanced sensitivity of a second generation ELISA for antibody to hepatitis C virus.

  Bresters D, Cuypers HT, Reesink HW, Schaasberg WP, van der Poel CL, Mauser-Bunschoten EP, Houghton M, Choo QL, Kuo G, Lesniewski R, et al. Bresters D, et al. Vox Sang. 1992;62(4):213-7. doi: 10.1111/j.1423-0410.1992.tb01201.x. Vox Sang. 1992. PMID: 1379394
• [Clinical and virological analysis of the non-A, non-B hepatitis negative for HCV antibody (anti-C-100)].

  Kamimura T, Miyajima T, Okoshi S, Kojima H, Asakura H, Shimotono K. Kamimura T, et al. Nihon Rinsho. 1991 Feb;49(2):409-11. Nihon Rinsho. 1991. PMID: 1849201 Japanese. No abstract available.
• [Serodiagnosis of hepatitis C by a recombinant hepatitis C virus protein].

  Hayashi N, Yuki N, Kasahara A, Fusamoto H, Kamada T. Hayashi N, et al. Nihon Rinsho. 1993 Feb;51(2):329-33. Nihon Rinsho. 1993. PMID: 7681883 Review. Japanese.
• Prevalence of hepatitis C virus infection among long-term hemodialysis patients: detection of hepatitis C virus RNA in plasma.

  Sakamoto N, Enomoto N, Marumo F, Sato C. Sakamoto N, et al. J Med Virol. 1993 Jan;39(1):11-5. doi: 10.1002/jmv.1890390104. J Med Virol. 1993. PMID: 7678636
• [Anti-HCV antibodies and transfusion recipients. Bibliographic data and current knowledge].

  Couroucé AM. Couroucé AM. Rev Fr Transfus Hemobiol. 1990 Oct;33(5):335-8. doi: 10.1016/s1140-4639(05)80039-5. Rev Fr Transfus Hemobiol. 1990. PMID: 2177594 Review. French. No abstract available.